Literature DB >> 18579512

Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.

Soo Jin Chae1, Jin Ju Kim, Young Min Choi, Kyu Ri Hwang, Byung Chul Jee, Seung Yup Ku, Chang Suk Suh, Seok Hyun Kim, Jung Gu Kim, Shin Yong Moon.   

Abstract

BACKGROUND: We investigated the differences in anthropometrical, hormonal and insulin resistance parameters according to the subtype of polycystic ovary syndrome (PCOS) in Korean women.
METHODS: We recruited 166 women with PCOS and retrospectively recruited 277 controls. PCOS was diagnosed by irregular menstruation (IM), polycystic ovary (PCO) and hyperandrogenism (HA). Subjects were divided into four subgroups: the IM/HA/PCO group (n = 87, 52.4%), the IM/PCO group (n = 52, 31.3%), the IM/HA group (n = 23, 13.9%) and the HA/PCO group (n = 4, 2.4%). Clinical and biochemical variables were compared among the PCOS subgroups.
RESULTS: The IM/HA/PCO and IM/HA groups showed higher body mass index (P < 0.001) and waist-to-hip ratio (P < 0.001) than the IM/PCO group. The IM/HA group had higher triglyceride levels than the other groups (P < 0.001). Higher fasting insulin (P < 0.001) and postprandial 2 h insulin (P < 0.01) were noted in the IM/HA/PCO group and the IM/HA group, compared with the IM/PCO group. Women with PCOS showed lower sex hormone-binding globulin (P < 0.001) and higher systolic blood pressure (BP) (P = 0.004), diastolic BP (P = 0.001), fasting insulin (P < 0.001), postprandial 2 h insulin (P < 0.001), homeostatic model for insulin resistance (P < 0.001) and clinical and biochemical parameters of metabolic syndrome (P < 0.05) compared with subjects without PCOS.
CONCLUSIONS: Women with PCOS without HA are common in Korea and are less likely to have metabolic dysfunction, insulin resistance and elevated BP. PCOS without HA may be a mild phenotype of PCOS. Therefore, women with PCOS in Korea could have a reduced likelihood of having metabolic syndrome compared with women of other ethnicities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579512     DOI: 10.1093/humrep/den239

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  29 in total

1.  Clinical outcomes of three- or five-day treatment with clomiphene citrate combined with gonadotropins and a timed intercourse cycle in polycystic ovary syndrome patients.

Authors:  Sung-Ah Bae; Jong-Kil Joo; Jong-Ryeol Choi; Sun-Suk Kim; Kyu-Sup Lee
Journal:  Clin Exp Reprod Med       Date:  2015-09-30

2.  Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women.

Authors:  Eun Youn Roh; Jong Hyun Yoon; Eun Young Song; Jin Ju Kim; Kyu Ri Hwang; Soo Hyun Seo; Sue Shin
Journal:  J Assist Reprod Genet       Date:  2016-10-29       Impact factor: 3.412

Review 3.  Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Michelle L Meyer; Angela M Malek; Robert A Wild; Mary T Korytkowski; Evelyn O Talbott
Journal:  Hum Reprod Update       Date:  2011-11-22       Impact factor: 15.610

4.  Vitamin D deficiency in women with polycystic ovary syndrome.

Authors:  Jin Ju Kim; Young Min Choi; Soo Jin Chae; Kyu Ri Hwang; Sang Ho Yoon; Min Jeong Kim; Sun Mie Kim; Seung Yup Ku; Seok Hyun Kim; Jung Gu Kim
Journal:  Clin Exp Reprod Med       Date:  2014-06-30

5.  Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome.

Authors:  Mahnaz Ashrafi; Fatemeh Sheikhan; Arezoo Arabipoor; Nicole Rouhana; Roya Hosseini; Zahra Zolfaghari
Journal:  Oman Med J       Date:  2017-05

6.  FSH receptor gene p. Thr307Ala and p. Asn680Ser polymorphisms are associated with the risk of polycystic ovary syndrome.

Authors:  Jin Ju Kim; Young Min Choi; Min A Hong; Soo Jin Chae; Kyuri Hwang; Sang Ho Yoon; Seung Yup Ku; Chang Suk Suh; Seok Hyun Kim
Journal:  J Assist Reprod Genet       Date:  2017-05-25       Impact factor: 3.412

7.  Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.

Authors:  Uche Ezeh; Bulent O Yildiz; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

8.  Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine.

Authors:  Ahmed M Mohamadin; Fawzia A Habib; Abdulrahman A Al-Saggaf
Journal:  Ann Saudi Med       Date:  2010 Jul-Aug       Impact factor: 1.526

9.  Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.

Authors:  V Vaggopoulos; E Trakakis; C Chrelias; P Panagopoulos; G Basios; S Makridima; V D Sioulas; G Simeonides; G Labos; E Boutati; D Kassanos
Journal:  J Endocrinol Invest       Date:  2012-11-27       Impact factor: 4.256

10.  Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study.

Authors:  Sujatha Thathapudi; Vijayalakshmi Kodati; Jayashankar Erukkambattu; Anuradha Katragadda; Uma Addepally; Qurratulain Hasan
Journal:  Genet Test Mol Biomarkers       Date:  2014-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.